Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
Taking a pharmaceutical product from early development to commercial launch requires a carefully orchestrated technology transfer process. It involves coordinating multiple stakeholders, understanding project-specific complexities, and maintaining a rigorous framework to assess business, regulatory, product quality, and technical risks continuously. By doing so, biotech and pharma companies can ensure their innovative products scale up efficiently and cost-effectively while meeting regulatory requirements worldwide.
Our whitepaper provides practical insights into this critical process, outlining common challenges and offering case-based solutions and best practices. At Thermo Fisher Scientific, we believe that partnering with an experienced CDMO tech transfer team can boost productivity, enhance efficiency, lower costs, improve regulatory readiness, and accelerate time to market. Download our whitepaper to learn more about our experienced and proactive approach to organization and operation, and how we can support your next project.